Dr. Xian-Zheng Zhang and co-workers have fabricated a biodegradable chimeric peptide for cancer therapy and real-time apoptosis imaging.
North American researchers have prepared luminescent core-shell nanoparticles from non-toxic silicon for use in biomedical imaging.
Xuesi Chen and co-workers from the Changchun Institute of Applied Chemistry explore the potential of combining chemotherapy with antiangiogenic therapy.
A research team have reported a novel and versatile strategy to assemble inorganic NPs into sub-50 nm vesicles.
The research article from Georgia Tech addresses an important issue in the current battle against cancer – the development of resistance to anticancer drugs, which leads to the loss of efficacy of chemotherapeutic treatment.
Unusual compound is the first metallic oxygen ion conductor of its kind, as well as the first that is active at room temperature.
ETH researchers have developed plasmonic particles that are relatively easy to produce and have a wide range of applications, including cancer treatment.
A study to investigate how nanoparticles could be used to improve the diagnosis and treatment of cardiovascular disease has received £3 million funding.
New method allows researchers to directly measure nanoparticle degradation in real time within biological environments.
Korean scientists have developed a tumor-targeted, bioreducible nanoparticle system that can deliver cytotoxic anticancer drugs to tumor tissues.